Abstract
The European Clinical Research Infrastructures Network (ECRIN) is designed to improve the capacity and quality of the clinical research in Europe and promote innovative pharmaceutical development. The regulation of the companysponsored clinical trials is functionally acceptable, but other type of investigations (investigator initiated trials, trials of psychology, food supplements, devices, etc.) needs further harmonisation. Hungary joined ECRIN in 2005 and performed a lot of queries in regulation, legislation, monitoring, safety, pharmacovigilance, data management, quality assurance, etc., which are presently summarized in this paper in order to show the present situation of the complicated issues of clinical research in Hungary. This “country report” summarizes the present legislative and regulatory frames including the necessary issues being attached: organizing and setting-up the first representatives of clinical study centres into a network, which will facilitate the organisation and performance of multinational studies in various research areas.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
